Package 0074-0039-56

{"route": ["ORAL"], "spl_id": "12b19eff-edfe-4218-96b3-f2446c6f2a6a", "openfda": {"unii": ["5948VUI423"], "rxcui": ["2049852", "2049858", "2049860", "2049862"], "spl_set_id": ["a86757b3-09c5-fd3b-1223-244e94f50a66"], "manufacturer_name": ["AbbVie Inc."], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": true, "description": "1 BLISTER PACK in 1 CARTON (0074-0039-14)  / 14 TABLET, FILM COATED in 1 BLISTER PACK", "package_ndc": "0074-0039-14", "marketing_start_date": "20180723"}, {"sample": false, "description": "4 BLISTER PACK in 1 CARTON (0074-0039-56)  / 14 TABLET, FILM COATED in 1 BLISTER PACK", "package_ndc": "0074-0039-56", "marketing_start_date": "20180723"}], "brand_name": "Orilissa", "product_id": "0074-0039_12b19eff-edfe-4218-96b3-f2446c6f2a6a", "dosage_form": "TABLET, FILM COATED", "pharm_class": ["Cytochrome P450 2C19 Inhibitors [MoA]", "Cytochrome P450 3A Inducers [MoA]", "Decreased GnRH Secretion [PE]", "Gonadotropin Releasing Hormone Receptor Antagonist [EPC]", "Gonadotropin Releasing Hormone Receptor Antagonists [MoA]", "P-Glycoprotein Inhibitors [MoA]"], "product_ndc": "0074-0039", "generic_name": "Elagolix", "labeler_name": "AbbVie Inc.", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "Orilissa", "active_ingredients": [{"name": "ELAGOLIX SODIUM", "strength": "200 mg/1"}], "application_number": "NDA210450", "marketing_category": "NDA", "marketing_start_date": "20180723", "listing_expiration_date": "20261231"}